Spring Sciences Australia still weighing up IPO and funding options after ‘tough’ 2025 by Adam Sheldon February 5, 2026February 5, 2026 Spring Sciences Australia is nearing a decision on whether to pursue an ASX listing or raise […]
Biortica executive quits cannabis to return to pharma sector by Steve Jones February 4, 2026February 5, 2026
Cannatrek ‘evolution’ key to merger, says LGP managing director by Adam Sheldon February 3, 2026February 5, 2026
Pastilles surge again as SAS-B data shows strong start to 2026 by Steve Jones February 2, 2026February 3, 2026
Financial news in brief: Avecho; InhaleRx; Neurotech; Peak; Zelira; Argent by Adam Sheldon February 2, 2026June 8, 2026
Cann Group to review guidance after starting post-NAB era with ‘unexpectedly’ soft revenue by Steve Jones January 30, 2026February 3, 2026
European growth helps LGP report record quarter of revenue by Steve Jones January 30, 2026February 3, 2026
Vitura Health CEO let go as board says ‘new leadership was required’ by Steve Jones January 29, 2026January 29, 2026
Full UIC program revealed as discount deadline extended for Cannabiz members by cannabiz team January 29, 2026June 8, 2026
Cannim directors face further probe as creditors urged to wind up company by Steve Jones January 29, 2026January 29, 2026
